Dr. Anastasia Sacharidou received her B. Sc. in Cell and Molecular Biology from University of Essex - UK, her M. Sc. in Molecular Medicine from Imperial College of London - UK, and her Ph.D. in Medical Pharmacology and Physiology from University of Missouri – Columbia. She received her 1st post-doctoral training in Vascular Biology, in the department of Medical Pharmacology and Physiology at the University of Missouri - Columbia, and her 2nd post-doctoral training in Vascular Biology in the department of Pediatrics at the University of Texas Southwestern Medical Center.
Dr. Sacharidou joined the faculty (Assistant Instructor) of the Center for Pulmonary and Vascular Biology in the department of Pediatrics, at the University of Texas Southwestern Medical Center after the completion of her postdoctoral studies in December 2017.
Dr. Sacharidou is part of the Mineo/Shaul Lab and is currently leading projects that investigate:
- The pregnancy complications of the antiphospholipid syndrome
- The beneficial effects of estrogen in glucose homeostasis
- The mediation of anti-inflammatory and anti-atherogenic effects of HDL on endothelial cells
- The apoE4-driven endothelial processes governing peripheral insulin sensitivity and thrombosis
- The role of the lipoprotein receptor ApoER2 on insulin sensitivity and atherosclerosis
Instructor, Center for Pulmonary and Vascular Biology, Department of Pediatrics.
Endothelial origins of insulin resistance and type 2 diabetes.
Pathogenesis of the Antiphospholipid Syndrome.
Endothelial origins of autoimmune disorders.
Honors and Awards
2016 Atherosclerosis, Thrombosis, and Vascular Biology Junior Investigator Award for Women.
2014-2017 T32 award, Training Program in Lung Biology and Disease, NHLBI/NIH.
Anastasia Sacharidou, Ph.D.
Center for Pulmonary and Vascular Biology
Department of Pediatrics
UT Southwestern Medical Center
5323 Harry Hines Blvd, K4.120
Dallas, TX, 75390-9063
Tel: (214) 648-8964
FAX: (214) 648-2096